Published Papers & Misc - IKEDA SADAKATSU

Division display  21 - 40 of about 76 ／  All the affair displays >>

  1. Takahashi Kenta, Gen Yasuyuki, Tanimoto Kousuke, Kudo Atsushi, Oshima Noriko, Ban Daisuke, Takemoto Akira, Onishi Iichiro, Kumaki Yuichi, Yokobori Junko, Takamine Eriko, Kano Yoshihito, Miyake Satoshi, Miyasaka Naoyuki, Tanabe Minoru, Inazawa Johji, Ikeda Sadakatsu. Clinical impact of hemizygous deletion detection and panel-size in comprehensive genomic profiling. JOURNAL OF CLINICAL ONCOLOGY. 2020.05; 38 (15):

  2. Kato S, Okamura R, Kumaki Y, Ikeda S, Nikanjam M, Eskander R, Goodman A, Lee S, Glenn ST, Dressman D, Papanicolau-Sengos A, Lenzo FL, Morrison C, Kurzrock R. Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity. Oncoimmunology. 2020; 9 (1): 1708065. ( PubMed, DOI )

  3. Peled N., Okuma H., Rotem O., Dudnik E., Ikeda S., Stemmer S. M., Olsen S.. Circulating tumour DNA (ctDNA) identifies actionable genetic alterations in Middle Eastern and Asian (MEA) patients diagnosed with carcinoma of unknown primary (CUP) ANNALS OF ONCOLOGY. 2019.11; 30

  4. Ono Hiroaki, Ikeda Sadakatsu, Ogawa Kosuke, Ogura Toshiro, Ban Daisuke, Kudo Atushi, Miyake Satoshi, Tanaka Shinji, Tanabe Minoru. Genomic sequencing in HBP malignancies(和訳中) 日本消化器病学会雑誌. 2019.11; 116 (臨増大会): A893. ( ichushi )

  5. Oshima N., Takahashi K., Nakamura R., Yoshino Y., Wakana K., Ikeda S., Miyasaka N.. CANCER GENOMIC AND PERSONALIZED MEDICINE FOR GYNECOLOGIC TUMORS IN OUR HOSPITAL INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019.11; 29 A416. ( DOI )

  6. Takahashi K., Kato S., Bamel K., Ikeda S., Plaxe S., Parker B., Kurzrock R.. EXCEPTIONAL RESPONSE WITH COMBINED ANTI-HORMONE AND MEK INHIBITOR THERAPY IN A PATIENT WITH HORMONE RECEPTOR-POSITIVE OVARIAN CANCER AND ISOLATED KRAS ALTERATION. IMPLICATIONS FOR A PRECISION MEDICINE STRATEGY INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019.11; 29 A524. ( DOI )

  7. Ono Hiroaki, Ikeda Sadakatsu, Ogawa Kosuke, Ogura Toshiro, Ban Daisuke, Kudo Atushi, Miyake Satoshi, Tanaka Shinji, Tanabe Minoru. HBP悪性疾患に関するゲノムシークエンス解析(Genomic sequencing in HBP malignancies) 日本消化器外科学会雑誌. 2019.11; 52 (Suppl.2): 306. ( ichushi )

  8. Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K, DLD/TO Assemblies of JRS. Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia. Respiratory investigation. 2019.11; 57 (6): 512-533. ( PubMed, DOI )

  9. 武藤 学, 金井 雅史, 鶴山 竜昭, 松本 繁巳, 豊岡 伸一, 秋田 弘俊, 松原 久裕, 西原 広史, 末岡 榮三朗, 池田 貞勝. バイオバンキングが切り拓く新しいがん研究　わが国におけるクリニカルバイオバンクネットワークの構築(Innovative cancer research based on biobanking　Clinical biobank network in Japan) 日本癌学会総会記事. 2019.09; 78回 S11-4. ( ichushi )

  10. Kaseb AO, Sánchez NS, Sen S, Kelley RK, Tan BR, Bocobo AG, Lim KH, Abdel-Wahab R, Uemura MI, Carmagnani Pestana R, Qiao W, Xiao L, Morris J, Amin HM, Hassam MM, Rashid A, Banks KC, Lanman RB, Talasaz A, Mills Shaw KR, George B, Haque A, Raghav K, Wolf RA, Yao JC, Meric-Bernstam F, Ikeda S, Kurzrock R. Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019.07; 25 (20): 6107-6118. ( PubMed, DOI )

  11. Yuichi Kumaki, Sadakatsu Ikeda, Thereasa A. Rich, Jing Zhao, Takayuki Yoshino, Byoung Chul Cho, Nir Peled, Ji-Youn Han, Yukimasa Shiotsu, Aleksandra Franovic, Victoria M. Raymond, Razelle Kurzrock, Richard B. Lanman, Jeeyun Lee, Tony S. K. Mok. Comprehensive genomic profiling of circulating cell-free DNA (cfDNA) distinguishes focal amplification (amp) from aneuploidy among MET amps in diverse advanced cancer types. Journal of Clinical Oncology. 2019.05; 37 (15): 3046. ( DOI )

  12. Kumaki Yuichi, Ikeda Sadakatsu, Rich Thereasa A., Zhao Jing, Yoshino Takayuki, Cho Byoung Chul, Peled Nir, Han Ji-Youn, Shiotsu Yukimasa, Franovic Aleksandra, Raymond Victoria M., Kurzrock Razelle, Lanman Richard B., Lee Jeeyun, Mok Tony S. K.. Comprehensive genomic profiling of circulating cell-free DNA (cfDNA) distinguishes focal amplification (amp) from aneuploidy among MET amps in diverse advanced cancer types. JOURNAL OF CLINICAL ONCOLOGY. 2019.05; 37 (15):

  13. Ikeda S., Kumaki Y., Rich T. A., Shiotsu Y., Franovic A., Raymond V. M., Kurzrock R., Lanman R. B., Lee J., Mok T. S. K.. Circulating cell-free DNA molecular profiling among east Asian patients reveals activating MET alterations are common in diverse advanced cancer types ANNALS OF ONCOLOGY. 2018.11; 29 116.

  14. Ikeda Sadakatsu, Elkin Sheryl K, Tomson Brett N, Carter Jennifer L, Kurzrock Razelle. Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing. Cancer Biol Ther. 2018.10; 1-8. ( PubMed, DOI )

  15. Machiels J-P., Licitra L., Tao Y. G., Yen C-J., Rischin D., Waldron J. N., Burtness B. A., Gregoire V., Agarwala S. S., Yorio J., Delord J-P., Aksoy S., Ikeda S., Hong R-L., Ge J. Y., Brown H., Bidadi B., Siu L. L.. KEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC) ANNALS OF ONCOLOGY. 2018.10; 29 398.

  16. Takahashi K., Oshima N., Nakamura R., Wakana K., Miyake S., Miyasaka N., Ikeda S.. OVARIAN MIXED BRENNER-MUCINOUS BORDERLINE TUMOR WITH BRAF V600E MUTATION INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2018.09; 28 848.

  17. Siu Lillian L., Licitra Lisa, Tao Yun Gan, Yen Chia-Jui, Rischin Danny, Waldron John, Burtness Barbara, Gregoire Vincent, Agarwala Sanjiv, Yorio Jeffrey, DeLord Jean-Pierre, Aksoy Sercan, Ikeda Sadakatsu, Hong Ruey-Long, Ge Joy Yang, Brown Holly, Bidadi Behzad, Machiels Jean-Pascal. KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma CANCER RESEARCH. 2018.07; 78 (13): ( DOI )

  18. Ikeda Sadakatsu, Schwaederle Maria, Mohindra Mandakini, Jardim Denis L. Fontes, Kurzrock Razelle. MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis JOURNAL OF HEMATOLOGY & ONCOLOGY. 2018.06; 11 76. ( DOI )

  19. Ikeda Sadakatsu, Schwaederle Maria, Mohindra Mandakini, Fontes Jardim Denis L, Kurzrock Razelle. MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis. J Hematol Oncol. 2018.06; 11 (1): 76. ( PubMed, DOI )

  20. Ikeda Sadakatsu, Tsigelny Igor F., Skjevik Age A., Kono Yuko, Mendler Michel, Kuo Alexander, Sicklick Jason K., Heestand Gregory, Banks Kimberly C., Talasaz AmirAli, Lanman Richard B., Lippman Scott, Kurzrock Razelle. Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma ONCOLOGIST. 2018.05; 23 (5): 586-593. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲